--:--:--

Sunil Healthcare Limited

Web: sunilhealthcare.com NSE: SUNLOC BSE: 537253 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

66 2(-3%)

Near 52W Low of 65

Volume

0k as on 18, Sep

Open

80

High

80

Low

78

Close

67

VWAP

73

52 Week High

82

52 Week Low

65

Viand Research Rating
Quality Score

32/100

Growth Score

40/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

67

No. of Shares

1.03

P/E

-275.34

P/B

1.07

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-0.39

ROCE

-

Profit Growth

-

Listing Date

Rank/Sector Rank

#3525/#209

Promoter Holding

73.53%

FII Holding

-

DII Holding

0.1%

Price Chart
Price Performance
1 Week3%
1 Month7%
3 Months8%
6 Months8%
1 Year8%
YTD8%
Moving Average
5 Day SMA74
10 Day SMA77
20 Day SMA76
30 Day SMA0
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 373737373
Resistance 273737373
Resistance 173737373
Pivot Point73737373
Support 173737373
Support 273737373
Support 373737373
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,24,84017712%4%7%7%3755.50.0711509
2DIVISLAB2,46,48892853%0%53%42%6955.502568
3TORNTPHARM1,76,59746433%6%11%32%7255.51.792138
4APOLLOHOSP1,13,17378711%11%5%1%5855.50.92003
5ZYDUSLIFE1,12,96711322%1%23%16%2055.50.313560
6LAURUSLABS1,11,27220593%5%88%132%055.50.48890
7CIPLA1,07,41413301%3%10%14%2255.50.023862
8DRREDDY1,03,49812403%6%0%0%2055.50.24158
9MANKIND97,97423725%4%14%3%4955.50.391938
10AUROPHARMA96,92816850%0%26%50%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
Promoters(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%(0.01) 73.53%
DIIs(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%(0.01) 0.10%
Public26.37%26.37%26.36%26.37%26.38%26.36%26.37%26.36%26.37%26.35%26.37%26.37%26.36%26.36%26.36%26.37%26.37%26.37%26.37%
No. of Shareholders6,3106,3646,3996,4306,4756,5416,5506,5076,5946,8587,0107,0817,0427,1117,0566,8336,4946,4416,370
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales18.9919.7221.8423.5222.6421.220.4620.2621.521.3122.6723.722.5121.2625.1830.6433.4131.6831.6129.19
Sales Growth % (YoY)-16.1%-7%6.7%16.1%5.3%-0.5%-9.8%-14.5%-4.5%0.2%-10%-22.6%-32.6%-32.9%-20.3%5%25.8%34.9%40.4%27.8%
Sales Growth % (QoQ)-3.7%-9.7%-7.1%3.9%6.8%3.6%1%-5.8%0.9%-6%-4.3%5.3%5.9%-15.6%-17.8%-8.3%5.5%0.2%8.3%-
Expenses16.0617.7818.2219.5919.3718.1717.7617.9519.2918.6323.322.4821.6918.5423.1726.5726.0524.5326.3726.89
Operating Profit2.931.943.623.933.273.032.72.312.212.68-0.631.220.822.722.014.077.367.155.242.3
OPM %15.439.8416.5816.7114.4414.2913.211.410.2812.58-2.785.153.6412.797.9813.2822.0322.5716.587.88
Other Income0.230.290.50.420.860.490.530.180.140.683.130.221.190.960.851.770.920.850.150.43
Interest1.51.661.661.41.441.561.891.51.511.761.441.311.271.171.071.10.820.770.740.91
Depreciation1.461.521.621.641.661.681.691.511.481.431.451.591.6121.671.711.631.571.611.58
Profit before tax0.2-0.950.841.311.030.28-0.35-0.52-0.640.17-0.39-1.46-0.870.510.123.035.835.663.040.24
Tax %-130-258.9530.9523.6611.65-28.5757.147.696.255.88-48.72-25.34-26.4411.76158.3330.0328.1329.3328.9587.5
Net Profit 0.461.520.5910.910.36-0.54-0.55-0.690.15-0.2-1.1-0.640.45-0.082.134.194.012.160.04
Net Profit Growth % (QoQ)-69.7%157.6%-41%9.9%152.8%166.7%1.8%20.3%-560%175%81.8%-71.9%-242.2%662.5%-103.8%-49.2%4.5%85.6%5300%-
Net Profit Growth % (YoY)-49.5%322.2%209.3%281.8%231.9%140%-170%50%-7.8%-66.7%-150%-151.6%-115.3%-88.8%-103.7%5225%----
TTM Net Profit3.574.022.861.730.18-1.42-1.63-1.29-1.84-1.79-1.49-1.371.866.6910.2512.4910.46.212.20
EPS in Rs0.451.480.580.980.890.35-0.53-0.54-0.670.15-0.2-1.07-0.620.44-0.082.084.093.912.110.04
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Sales87.7283.4290.19110.49119.1690.6270.0280.8891.33108.48
Sales Growth %5.2%-7.5%-18.4%-7.3%31.5%29.4%-13.4%-11.4%-15.8%-
Expenses74.9573.0685.9394.32101.7885.2776.9569.6277.4493.33
Operating Profit12.7710.364.2616.1717.385.35-6.9311.2613.8915.15
OPM %14.5612.424.7214.6314.595.9-9.913.9215.2113.97
Other Income2.061.245.054.51.685.5214.410.182.231.25
Interest6.166.465.784.173.495.316.956.585.034.18
Depreciation6.446.356.097.016.316.116.135.744.784.33
Profit before tax2.23-1.21-2.569.499.26-0.55-5.6-0.886.317.89
Tax %-79.3716.53-30.0829.530.6716.36-11.25-20.4528.6836.25
Net Profit 4.01-1.42-1.796.686.42-0.64-4.96-0.694.495.03
Net Profit Growth %382.4%20.7%-126.8%4%1103.1%87.1%-618.8%-115.4%-10.7%-
EPS in Rs3.91-1.38-1.756.516.26-0.62-4.84-0.674.384.91
Dividend Payout %0000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Cash from Operating Activity22.1511.52-15.47.4722.5116.994.3114.735.4810.79
Cash from Investing Activity-2.85-7.7-10.11-3.4-4.24-11.36-2.52-2.8-17.18-12.85
Cash from Financing Activity-19.26-3.8725-3.75-18.56-6.42-1.56-11.6311.022.23
Net Cash Flow0.04-0.05-0.510.32-0.29-0.790.230.3-0.670.17
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Equity Capital10.2510.2510.2510.2510.2510.2510.2510.2510.2510.2510.2510.25
Reserves59.3557.7156.8157.2557.9645.7439.733.4634.3436.5237.1832.65
Borrowings55.796068.6561.6366.1536.7934.6849.8249.4555.0860.6244.53
Other Liabilities39.1231.2226.2329.7324.1328.0125.0627.0336.1935.8834.1631.41
Total Liabilities164.51159.18161.94158.86158.49120.79109.69120.56130.23137.73142.21118.84
Fixed Assets85.8592.5294.0895.4987.1670.4369.9769.869.9768.8370.9259.72
CWIP1.770.180.090.025.660.011.750.010.012.470.190.12
Investments00.100001.031.070.110.110.10
Other Assets76.8966.3867.7763.3565.6750.3536.9449.6860.1466.327159
Total Assets164.51159.18161.94158.86158.49120.79109.69120.56130.23137.73142.21118.84
Delivery

Delivery Data: SUNLOC

#Date
65
26%
82
Value (Cr)Q/T
51
Del
58
Del
0
113-Oct66
0
141000
212-Oct67
0
7850
39-Oct66
0
23900
48-Oct72
0
4660
57-Oct70
0
41000
66-Oct68
0
151000
75-Oct68
0
15980
81-Oct70
0
75160
930-Sep69
0
19400
1029-Sep68
0
21000
1128-Sep71
0
11000
1225-Sep71
0
81000
1324-Sep72
0
121000
1422-Sep76
0
30520
1521-Sep73
0
251000
1618-Sep73
0
11000
1717-Sep73
0
201000
1816-Sep73
0
6450
1915-Sep76
0
511000
2011-Sep76
0
1011000
2110-Sep76
0
351000
229-Sep78
0
15990
238-Sep80
0
101960
247-Sep80
0
31000
254-Sep80
0
201000
263-Sep80
0
421000
272-Sep80
0
24890
281-Sep80
0
33790
2931-Aug81
0
40840
3028-Aug76
0
41840
3126-Aug70
0
111000
3225-Aug70
0
17980
3324-Aug72
0
12840
3421-Aug69
0
13990
3520-Aug68
0
131000
3618-Aug68
0
30460
3717-Aug68
0
6610
Daily Market Cap
DateTotal Market CapChangeChg %
13-Oct67c21L0.30
12-Oct67c5c6.82
09-Oct72c2c2.74
08-Oct74c5c6.62
06-Oct70c6c7.98
05-Oct76c3c4.08
01-Oct73c10L0.14
28-Sep73c1c1.49
25-Sep74c4c5.05
22-Sep78c3c3.78
10-Sep81c1c1.50
07-Sep82c00
04-Sep82c1L0.01
03-Sep82c2c2.55
01-Sep80c2c1.96
31-Aug78c00
Stock Checklist
Price is above from 52 week high low average: 1%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0